Successful treatment of enterovirus-infected mice by 2-(α-Hydroxybenzyl)-benzimidazole and guanidine*

32Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Echo virus 9- or Coxsackie A 9-infected newborn mice are protected from paralysis and death by combined treatment with nontoxic concentrations of HBB plus guanidine. HBB alone also protects Coxsackie A 9, but not echo virus 9-infected animals, whereas guanidine alone is ineffective in either case. Protection is due to inhibition of virus multiplication via the antiviral activity of these selective inhibitors. Treatment must be begun a t the latest 48 h after virus inoculation. 3 days of treatment are sufficient if started at the time of virus inoculation. Failure of protection after treatment with one compound alone is not due to rapid development of drug-resistant virus mutants. Infected, successfully treated mice may develop a solid immunity. © 1976, Rockefeller University Press., All rights reserved.

Cite

CITATION STYLE

APA

Eggers, H. J. (1976). Successful treatment of enterovirus-infected mice by 2-(α-Hydroxybenzyl)-benzimidazole and guanidine*. Journal of Experimental Medicine, 143(6), 1367–1381. https://doi.org/10.1084/jem.143.6.1367

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free